![Iktos announces the acquisition of Synsight](https://images.prismic.io/iktos/ZohFjh5LeNNTw1FT_IktosSynsight_light.jpg?auto=compress,format)
Iktos’s vision
Iktos stands at the forefront of drug discovery innovation, combining AI and robotics to tackle the inefficiencies of traditional drug development processes.
Our mission is to enable faster discovery of effective treatments, advancing global health by bringing new solutions to patients more quickly and reliably.
milestones and achievements
A Track Record of Success
From our founding in 2016 to the present, Iktos has achieved key milestones :
Founding of Iktos
First successful pharma collaborations
Launching of generative AI platform (Makya)
Launching of retrosynthesis AI platform (Spaya)
Series A 15.5M€
Initiation of in-house drug discovery
Seamless integration of Spaya and Makya
Integration of Robotics
Meet our Team
Meet the dedicated team behind Iktos’s success, comprising industry-leading experts in AI, robotics, and pharmaceutical sciences.
founders and board
executive committee
MANAGEMENT TEAM
Meet us at :
Partner with Iktos
Embark with us
Since our inception in 2018, we have consistently delivered value through over 60 collaborations with leading pharmaceutical, biotech, and academic institutions. Our highly skilled team is dedicated to pushing the boundaries of AI-driven drug design, making us a trusted partner in your molecular odyssey.
Get Started Today
Explore how Iktos’s groundbreaking solutions can accelerate your drug discovery projects. Contact us to learn more and request a demo of our platforms.
![Get Started Today](https://images.prismic.io/iktos/ZmdvgZm069VX1nTE_molecule-fs8.png?auto=compress,format)
recent Articles about iktos